Skip to Main Content

Naralys Sinanis, Program Manager, OCM

Nara standing infront of her desk
In 2016, Smilow Cancer Hospital/Yale Medicine were selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Oncology Care Model (OCM) program. OCM supports and encourages higher quality, more coordinated cancer care with lower costs. As the OCM Program Manager, Naralys "Nara" Sinanis oversees Smilow's participation in this model as well as all of the care model's requirements, ensuring Smilow stays within the guidelines set by the CMS.

Nara works closely with Smilow's OCM Executive team, helping to set goals to support our participation in the care model. Such goals can include reducing hospitalizations and visits to the emergency department. Day to day, Nara also works with tumor registry staff, data analysts, and care coordinators across our Network to track clinical and quality measures and to assess opportunities for improvement. Nara is responsible for reporting performance data to CMS and staying up to date on changes to the model's requirements.

"As the manager of this complex program, Naralys has taken ownership of every aspect of implementation and execution--from understanding complex patient eligibility criteria, developing novel billing workflows, overseeing quality reporting, and most importantly supervising implementation of new clinical programs," said Kerin Adelson, MD, Chief Quality Officer and Associate Chief Medical Officer for Smilow Cancer Hospital. "She built workgroups with stakeholders from across the YNHH and Yale Medicine. Using revenue from OCM to fund clinical infrastructure, Naralys has overseen the opening of our Oncology Extended Care Center - open 16 hours a day, 7 days a week - the development of a care management program and launch of Via Oncology clinical decision support which required a complex EPIC integration."

"Our success in this program is clear through steady improvements in hospital admission rates, ED visits, and reductions in use of post-acute care," continued Dr. Adelson. "Our primary motivation in electing to participate in this program was to improve patient care and learn about how to succeed in a value-based environment. Our financial success in the program is an added bonus. We have earned maximal quality points in all performance periods so far and this has led to significant performance-based payments. None of this would have been possible without Naralys' dedication and commitment to care transformation."

"Our OCM team genuinely cares about quality improvement and making a difference for our patients and families," said Nara. "It's energizing to receive positive feedback from patients and providers about our care coordinators and our extended care clinic. To me, that feedback is the most compelling data we have to show that this program is truly enhancing care."